MR

Mamta Rani

Active Director Director DIN 11110178
DIN 11110178 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mamta Rani

Data last updated:

Mamta Rani is a Director at Shiv Healthcare Parenterals Limited (since 2025) and Director at Shiv Biochem Private Limited (since 2025). The companies operate in Pharma.

DIN 11110178
Primary Designation Director
Industry Pharma
First Appointment 16 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shiv Healthcare Parenterals Limited U21000HP2025PLC012004
Director12 Sep 20252025Active
Shiv Biochem Private Limited U21000HP2025PTC011716
Director16 May 20252025Active

Board colleagues of Mamta Rani

Directorship timeline

Open interactive timeline →
Shiv Healthcare Parenterals Limited
Shiv Biochem Private Limited
Premium access

Shareholding and investment profile for Mamta Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Rani

Mamta Rani currently holds 2 directorships: Shiv Healthcare Parenterals Limited (Director, since 12 Sep 2025); Shiv Biochem Private Limited (Director, since 16 May 2025).

Mamta Rani was first appointed on 16 May 2025 as Director at Shiv Biochem Private Limited.

The current boards of Mamta Rani's companies include Naresh Kumar (Shiv Healthcare Parenterals Limited), Sushil Kumar (Shiv Healthcare Parenterals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available